Reuters -- Shares of Sequenom Inc shot up 17 percent on Monday amid speculations that the genetic analysis products maker may soon release positive results on its prenatal Down Syndrome test.
Reuters -- Shares of Sequenom Inc shot up 17 percent on Monday amid speculations that the genetic analysis products maker may soon release positive results on its prenatal Down Syndrome test.
